Cormorant Asset Management’s Agile Therapeutics AGRX Stock Holding History

Cormorant Asset Management’s Portfolio AGRX Stock Details AGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-625	Closed	-$5.58M	–	58
2017 Q3	$5.58M	Hold	625	–	–	1.01%	31
2017 Q2	$4.69M	Hold	625	–	–	0.78%	38
2017 Q1	$4.01M	Buy	625 +343	+122%	+$1.72M	0.58%	45
2016 Q4	$3.21M	Hold	282	–	–	0.43%	50
2016 Q3	$3.94M	Hold	282	–	–	0.43%	58
2016 Q2	$4.29M	Buy	282 +3	+1%	+$41.1K	0.61%	46
2016 Q1	$3.46M	Buy	279 +188	+207%	+$2.43M	0.52%	47
2015 Q4	$1.78M	Hold	91	–	–	0.21%	63
2015 Q3	$1.23M	Hold	91	–	–	0.2%	69
2015 Q2	$1.56M	Hold	91	–	–	0.21%	64
2015 Q1	$1.69M	Buy	91 +16	+21%	+$280K	0.26%	57
2014 Q4	$921K	Hold	75	–	–	0.14%	64
2014 Q3	$1.09M	Hold	75	–	–	0.23%	59
2014 Q2	$1.31M	Buy	+75	New	+$1.09M	0.35%	50

Other funds holding AGRX

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return